Prelude Capital Management, LLC Pfizer Inc Call Options Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $294,462 - $333,576	-8,200 Reduced 52.9%	7,300 $241,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $1.42 Million - $1.61 Million	-42,500 Reduced 73.28%	15,500 $562,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $1.85 Million - $2.35 Million	55,200 Added 1971.43%	58,000 $2.14 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $24,096 - $29,232	-800 Reduced 22.22%	2,800 $92,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $1.23 Million - $1.76 Million	-45,600 Reduced 92.68%	3,600 $118,000

Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $1.28 Million - $1.46 Million	-39,000 Reduced 44.22%	49,200 $1.93 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $2.87 Million - $3.72 Million	88,200 New	88,200 $3.17 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $924,499 - $1.04 Million	-25,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $937,500 - $1.03 Million	25,000 New	25,000 $1.06 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $2.17 Million - $2.52 Million	-68,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $2.26 Million - $2.4 Million	68,000	68,000 $2.46 Million

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.